PROM1 and hepatocellular carcinoma: In this paper, we have developed an in vitro co-culture system of HCC cells with hepatocytes to recapitulate tumor heterogeneity to identify CD133+ HCC-specific drugs in co-cultures of HCC cells with hepatocytes and have performed image-based phenotypic drug screening for the development of HCC therapeutics.